From the perspective of CMC, how to speed up the BLA declaration of biologics

From the perspective of CMC, how to speed up the BLA declaration of biologics

From the perspective of CMC, how to speed up the BLA declaration of biologics

随着疫情的常态化，更多项目数据将支持监管机构进行科学评估，以进一步催生生物工艺开发的变革，生物药的研发周期也有望进一步压缩。本白皮书将简要从 CMC 角度阐述如何加速生物制剂 BLA 的申报策略。

Added Date:

2023-02-19

Filters:

Filter Category	Filter Values
Specialty	Commercial manufacturing
Capability	Biologics
Language	Chinese
Asset Type	Whitepaper
Country	China
Region	Asia Pacific (APAC)
Market Category	Large molecule
Content Category	Collateral

Country Availability:

()

Gated Form:

None Set